Χώρα: Ηνωμένο Βασίλειο
Γλώσσα: Αγγλικά
Πηγή: VMD (Veterinary Medicines Directorate)
Meloxicam
Boehringer Ingelheim Vetmedica Gmbh
QM01AC06
Meloxicam
Oral suspension
POM-V - Prescription Only Medicine – Veterinarian
Horses
Anti Inflammatory NSAID
Authorized
2003-10-08
EMA Version September 2021- AN: 01220/2021 Page 1 of 5 SUMMARY OF PRODUCT CHARACTERISTICS 1. NAME OF THE VETERINARY MEDICINAL PRODUCT Metacam 15 mg/ml oral suspension for horses 2. QUALITATIVE AND QUANTITATIVE COMPOSITION One ml contains: ACTIVE SUBSTANCE: Meloxicam 15 mg EXCIPIENT: Sodium benzoate 1.5 mg For the full list of excipients, see section 6.1. 3. PHARMACEUTICAL FORM Oral suspension Yellowish viscous oral suspension with a green tinge. 4. CLINICAL PARTICULARS 4.1 TARGET SPECIES Horses 4.2 INDICATIONS FOR USE, SPECIFYING THE TARGET SPECIES Alleviation of inflammation and relief of pain in both acute and chronic musculo-skeletal disorders in horses. 4.3 CONTRAINDICATIONS Do not use in pregnant or lactating mares. Do not use in horses suffering from gastrointestinal disorders such as irritation and haemorrhage, impaired hepatic, cardiac or renal function and haemorrhagic disorders. Do not use in cases of hypersensitivity to the active substance or to any of the excipients. Do not use in horses less than 6 weeks of age. 4.4 SPECIAL WARNINGS FOR EACH TARGET SPECIES None. EMA Version September 2021- AN: 01220/2021 Page 2 of 5 4.5 SPECIAL PRECAUTIONS FOR USE Special precautions for use in animals Avoid use in any dehydrated, hypovolaemic or hypotensive animals as there is a potential risk of renal toxicity. Special precautions to be taken by the person administering the veterinary medicinal product to animals People with known hypersensitivity to non- steroidal anti-inflammatory drugs (NSAIDs) should avoid contact with the veterinary medicinal product. In case of accidental ingestion, seek medical advice immediately and show the package leaflet or the label to the physician. This product can cause eye irritation. In case of contact with the eyes, immediately rinse thoroughly with water. 4.6 ADVERSE REACTIONS (FREQUENCY AND SERIOUSNESS) Diarrhoea, typically associated with NSAIDs, was very rarely observed in clinical trials. The clinical sign was reversible. Loss of appetite, lethargy, abdominal pain, colitis a Διαβάστε το πλήρες έγγραφο